Harold E. van Wart
Director/Miembro de la Junta en Idun Pharmaceuticals, Inc. .
Cargos activos de Harold E. van Wart
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Idun Pharmaceuticals, Inc.
 Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Director/Miembro de la Junta | - | - |
Historial de carrera de Harold E. van Wart
Antiguos cargos conocidos de Harold E. van Wart.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/01/2003 | 01/01/2017 |
| Director Ejecutivo | 01/01/2003 | 29/03/2017 | |
| Director de Operaciones | 01/12/2001 | 01/01/2003 | |
| Director Técnico/Científico/I+D | 01/10/2000 | 01/12/2002 | |
| Presidente | 01/01/2001 | 29/03/2017 | |
| The Bay Area Bioscience Association | Director/Miembro de la Junta | - | - |
| Presidente | - | 26/12/2014 | |
| Syntex Corp. | Corporate Officer/Principal | 01/01/1992 | 01/01/2000 |
| Florida State University | Corporate Officer/Principal | 01/01/1978 | 01/01/1992 |
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology California Biomedical Innovation Alliance provides biomedical advocacy and community services. The private company is based in South San Francisco, CA and has subsidiaries in United States. The CEO of the company is Sara Radcliffe. | Presidente | - | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Miembro de la Junta | - | - |
| HISTOGEN INC. | Director/Miembro de la Junta | 01/03/2007 | - |
| Independent Dir/Board Member | 01/03/2007 | - |
Formación de Harold E. van Wart.
| Cornell University | Doctorate Degree |
| State University of New York at Binghamton | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 11 |
Operativa
| Director/Board Member | 5 |
| Corporate Officer/Principal | 2 |
| Chairman | 2 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Conatus Pharmaceuticals, Inc.
 Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
| The Bay Area Bioscience Association | Health Technology |
Idun Pharmaceuticals, Inc.
Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Health Technology |
| Syntex Corp. | Health Technology |
California Biomedical Innovation Alliance
California Biomedical Innovation Alliance BiotechnologyHealth Technology California Biomedical Innovation Alliance provides biomedical advocacy and community services. The private company is based in South San Francisco, CA and has subsidiaries in United States. The CEO of the company is Sara Radcliffe. | Health Technology |
- Bolsa de valores
- Insiders
- Harold E. van Wart
- Experiencia
